From: Effects of paliperidone extended release on the symptoms and functioning of schizophrenia
Time | Overall (N = 480) | ITT (N = 426) |
---|---|---|
Total | 130 (27.1%) | 76 (17.8%) |
Death | 1 (0.2%) | 1 (0.2%) |
Adverse Event | 23 (4.8%) | 17 (4.0%) |
Insufficient Response | 18 (3.8%) | 16 (3.8%) |
Ineligible to Continue | 15 (3.1%) | 0 (0.0%) |
Lost to Follow-up | 28 (5.8%) | 16 (3.8%) |
Withdrew Consent | 35 (7.3%) | 19 (4.5%) |
Non-Compliant | 8 (1.7%) | 5 (1.2%) |
Other | 2 (0.4%) | 2 (0.5%) |